Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 2,483 | 5,337 | 5,977 | 5,289 | 2,211 |
| Cost of Goods | 536 | 1,505 | 1,986 | 1,358 | 593 |
| Gross Profit | 1,947 | 3,832 | 3,991 | 3,931 | 1,618 |
| Operating Expenses | 13,549 | 12,358 | 12,346 | 13,202 | 16,017 |
| Operating Income | -11,066 | -8,021 | -7,369 | -8,913 | -13,806 |
| Other Income | 1,581 | 993 | -779 | 1,057 | -1,825 |
| Pre-tax Income | -9,485 | -7,028 | -8,148 | -7,856 | -15,631 |
| Income Tax | 55 | 25 | 26 | 121 | 64 |
| Net Income Continuous | -9,540 | -7,053 | -8,174 | -7,977 | -15,695 |
| Net Income | $-9,540 | $-7,053 | $-8,174 | $-7,977 | $-15,695 |
| EPS Basic Total Ops | -0.26 | -0.19 | -0.27 | -0.26 | -0.52 |
| EPS Basic Continuous Ops | -0.26 | -0.19 | -0.26 | -0.27 | -0.52 |
| EPS Diluted Total Ops | -0.26 | -0.19 | -0.27 | -0.26 | -0.52 |
| EPS Diluted Continuous Ops | -0.26 | -0.19 | -0.26 | -0.27 | -0.52 |
| EPS Diluted Before Non-Recurring Items | 0.26 | -0.19 | -0.27 | -0.26 | -0.52 |
| EBITDA(a) | $-10,931 | $-7,921 | $-7,260 | $-8,766 | $-13,665 |